Overview of nosocomial infections caused by gram-negative bacilli

Clinical Infectious Diseases

Volumn 41, Issue 6, 2005, Pages 848-854

  Gaynes, Robert ^a,b   Edwards, Jonathan R ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT; AZTREONAM; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; IMIPENEM;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; GRAM NEGATIVE BACTERIUM; HEALTH SURVEY; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; SURGICAL INFECTION; URINARY TRACT INFECTION;

CROSS INFECTION; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; NATIONAL HEALTH PROGRAMS; PNEUMONIA, BACTERIAL; POPULATION SURVEILLANCE; SEPSIS; SURGICAL WOUND INFECTION; TIME FACTORS; UNITED STATES; URINARY TRACT INFECTIONS;

EID: 24644515282     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/432803     Document Type: Article

References (22)

1. Weinstein RA. Epidemiology and control of nosocomial infections in adult intensive care units. Am J Med 1991; 91(Suppl 3B):179S-84S.
2. Emori TG, Culver DH, Horan TC, et al. National Nosocomial Infections Surveillance System: description of surveillance methodology. Am J Infect Control 1991; 19:19-35.
3. Horan TC, Gaynes RP. Surveillance of nosocomial infections. In: Mayhall CG, ed. Hospital epidemiology and infection control. 3rd ed. Baltimore, MD: Lippincott Williams & Wilkins, 2004:1659-702.
4. Schwaber MJ, Raney PM, Rasheed JK, et al. Utility of NCCLS guidelines for identifying extended-spectrum β-lactamases in non-Escherichia coli and non-Klebsiella spp. of Enterobacteriaceae. J Clin Microbiol 2004; 42:294-8.
5. Banerjee S, Emori G, Culver DH, et al. Trends in nosocomial blood-stream infections in the United States, 1980-89. The National Nosocomial Infections Surveillance (NNIS) System. Am J Med 1991; 91(Suppl 3B):86S-9S.
6. Richards C, Edwards J, Culver D, Emori TG, Tolson J, Gaynes R. The impact of laparoscopy on surgical site infections following cholecystectomy. Ann Surg 2003; 237:358-62.
7. Abbo A, Navon-Venezia S, Hammer-Muntz O, Krichali T, Siegman-Igra Y, Carmeli Y. Multidrug-resistant Acinetobacter baumannii. Emerg Infect Dis 2005; 11:22-9.
8. Maslow JN, Glaze T, Adams P, Lataillade M. Concurrent outbreak of multidrug-resistant and susceptible subclones of Acinetobacter baumannii affecting different wards of a single hospital. Infect Control Hosp Epidemiol 2005; 26:69-75.
9. Archibald LK. Gram-negative, hospital-acquired infections: a growing problem. Infect Control Hosp Epidemiol 2004; 25:809-11.
10. Fridkin SK, Welbel SF, Weinstein RA. Magnitude and prevention of nosocomial infections in the intensive care unit. Infect Dis Clin North Am 1997; 11:479-95.
11. Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe: results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995; 274:639-44.
12. Kesah CN, Egri-Okwaji MT, Iroha E, Odugbemi TO. Aerobic bacterial nosocomial infections in paediatric surgical patients at a tertiary health institution in Lagos, Nigeria. Niger Postgrad Med J 2004; 11:4-9.
13. Spelman DW. Hospital-acquired infections. Med J Aust 2002; 176:286-91.
14. Erbay H, Yalcin AN, Serin S, et al. Nosocomial infections in intensive care unit in a Turkish university hospital: a 2-year survey. Intensive Care Med 2003; 29:1482-8.
15. Richet H. Acinetobacter among nosocomial infections. Clin Infect Dis, in press.
16. Hageman JC, Fridkin SK, Mohammed JM, Steward CD, Gaynes RP, Tenover FC. Antimicrobial proficiency testing of National Nosocomial Infections Surveillance System hospital laboratories. Infect Control Hosp Epidemiol 2003; 24:356-61.
17. Karlowsky JA, Jones ME, Thornsberry C, Friedland IR, Sahm DF. Trends in antimicrobial susceptibilities among Enterobacteriaceae isolated from hospitalized patients in the United States from 1998 to 2001. Antimicrob Agents Chemother 2003; 47:1672-80.
18. Streit JM, Jones RN, Sader HS, Fritsche TR. Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program. Int J Antimicrob Agents 2004; 24:111-8.
19. Monnet DL, Biddle JW, Edwards JR, et al. Evidence of interhospital transmission of extended-spectrum β-lactam-resistant Klebsiella pneumoniae in the United States, 1986-1993. Infect Control Hosp Epidemiol 1997; 18:492-8.
20. Blomberg B, Mwakagile DS, Urassa WK, et al. Surveillance of antimicrobial resistance at a tertiary hospital in Tanzania. BMC Public Health 2004; 4:45.
21. Tokars JI, Richards C, Andrus M. The changing face of surveillance for health care-associated infections. Clin Infect Dis 2004; 39:1347-52.
22. D'Agata EM. Rapidly rising prevalence of nosocomial multidrug-resistant, gram-negative bacilli: a 9-year surveillance study. Infect Control Hosp Epidemiol 2004; 25:842-6.